Jinxia Zhao

1.4k total citations
78 papers, 985 citations indexed

About

Jinxia Zhao is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Jinxia Zhao has authored 78 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Rheumatology, 20 papers in Immunology and 15 papers in Molecular Biology. Recurrent topics in Jinxia Zhao's work include Rheumatoid Arthritis Research and Therapies (25 papers), Systemic Lupus Erythematosus Research (13 papers) and Autoimmune and Inflammatory Disorders Research (10 papers). Jinxia Zhao is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (25 papers), Systemic Lupus Erythematosus Research (13 papers) and Autoimmune and Inflammatory Disorders Research (10 papers). Jinxia Zhao collaborates with scholars based in China, United States and Hong Kong. Jinxia Zhao's co-authors include Lin Sun, Zhanguo Li, Xiangyuan Liu, Changhong Li, Rulin Jia, Rui Xing, Zhenzhen Ma, Xiangyuan Liu, Rui Liu and Yi Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Small.

In The Last Decade

Jinxia Zhao

69 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinxia Zhao China 18 433 294 269 204 137 78 985
Thomas Karonitsch Austria 19 464 1.1× 236 0.8× 355 1.3× 151 0.7× 142 1.0× 41 984
Toru Yago Japan 17 480 1.1× 446 1.5× 465 1.7× 267 1.3× 130 0.9× 60 1.2k
Zhizhong Ye China 19 429 1.0× 327 1.1× 363 1.3× 124 0.6× 98 0.7× 58 1.1k
Toshiyuki Bohgaki Japan 21 459 1.1× 449 1.5× 260 1.0× 177 0.9× 243 1.8× 65 1.2k
Carl Orr Ireland 16 494 1.1× 281 1.0× 377 1.4× 166 0.8× 163 1.2× 23 1.0k
Nida Meednu United States 17 268 0.6× 373 1.3× 411 1.5× 165 0.8× 58 0.4× 25 964
Maria I. Zervou Greece 22 353 0.8× 235 0.8× 666 2.5× 152 0.7× 70 0.5× 88 1.3k
José Ramón Lamas Spain 20 422 1.0× 289 1.0× 423 1.6× 115 0.6× 81 0.6× 54 1.0k
Anne Crilly United Kingdom 17 608 1.4× 395 1.3× 312 1.2× 222 1.1× 218 1.6× 34 1.4k
Mitsuhiro Iwahashi Japan 12 366 0.8× 153 0.5× 449 1.7× 147 0.7× 238 1.7× 18 914

Countries citing papers authored by Jinxia Zhao

Since Specialization
Citations

This map shows the geographic impact of Jinxia Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinxia Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinxia Zhao more than expected).

Fields of papers citing papers by Jinxia Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinxia Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinxia Zhao. The network helps show where Jinxia Zhao may publish in the future.

Co-authorship network of co-authors of Jinxia Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Jinxia Zhao. A scholar is included among the top collaborators of Jinxia Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinxia Zhao. Jinxia Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jingyi, et al.. (2025). Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome. Journal of Translational Medicine. 23(1). 56–56.
2.
Xu, Jingyi, Changhong Li, Jinxia Zhao, & Rong Mu. (2025). Shared immunological pathways in rheumatoid arthritis-related interstitial lung disease. Frontiers in Immunology. 16. 1630729–1630729.
3.
5.
Li, Changhong, Fengliang Wang, Yinji Jin, et al.. (2024). Nitazoxanide reduces inflammation and bone erosion in mice with collagen-induced arthritis via inhibiting the JAK2/STAT3 and NF-κB pathways in fibroblast-like synoviocytes. Biomedicine & Pharmacotherapy. 171. 116195–116195. 9 indexed citations
7.
Li, Yuanyuan, Ying Zhang, Jinxia Zhao, et al.. (2023). Individualized treatment with voriconazole in the Chinese population: Inflammation level as a novel marker for dose optimization. British Journal of Clinical Pharmacology. 90(2). 440–451. 5 indexed citations
8.
Tao, Cheng, Feifei Li, Zhenzhen Ma, et al.. (2023). Highly Efficient Oral Iguratimod/Polyvinyl Alcohol Nanodrugs Fabricated by High‐Gravity Nanoprecipitation Technique for Treatment of Rheumatoid Arthritis. Small. 20(13). e2304150–e2304150. 3 indexed citations
9.
He, Shiyu, Jinxia Zhao, Yuanyuan Li, et al.. (2023). Population Pharmacokinetics and Pharmacogenetics Analyses of Dasatinib in Chinese Patients with Chronic Myeloid Leukemia. Pharmaceutical Research. 40(10). 2413–2422. 2 indexed citations
11.
Li, Changhong, Zhenzhen Ma, Xinyu Wang, et al.. (2020). Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways. International Immunopharmacology. 90. 107219–107219. 24 indexed citations
12.
Yu, Ruiyang, et al.. (2018). Hypoxia induces production of citrullinated proteins in human fibroblast‐like synoviocytes through regulating HIF. Scandinavian Journal of Immunology. 87(4). e12654–e12654. 22 indexed citations
13.
Yang, Yue, Mengtao Li, Yuan Jia, et al.. (2017). Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China. Clinical Rheumatology. 37(1). 93–100. 52 indexed citations
14.
Li, Changhong, Linlin Xu, Jinxia Zhao, et al.. (2015). CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway. Inflammation Research. 65(3). 193–202. 48 indexed citations
15.
Li, Changhong, Jinxia Zhao, Lin Sun, et al.. (2012). RANKL downregulates cell surface CXCR6 expression through JAK2/STAT3 signaling pathway during osteoclastogenesis. Biochemical and Biophysical Research Communications. 429(3-4). 156–162. 26 indexed citations
16.
Zhao, Jinxia, Xiangyuan Liu, Zhimin Wang, Rui Liu, & Zhanguo Li. (2010). Is It Necessary to Combine Detection of Anticitrullinated Protein Antibodies in the Diagnosis of Rheumatoid Arthritis?. The Journal of Rheumatology. 37(12). 2462–2465. 11 indexed citations
17.
Zhao, Jinxia, Xiangyuan Liu, Zhimin Wang, & Zhanguo Li. (2009). Significance of anti-CCP antibodies in modification of 1987 ACR classification criteria in diagnosis of rheumatoid arthritis. Clinical Rheumatology. 29(1). 33–38. 12 indexed citations
18.
Liu, Xia, Rulin Jia, Jinxia Zhao, & Zhanguo Li. (2009). The Role of Anti-Mutated Citrullinated Vimentin Antibodies in the Diagnosis of Early Rheumatoid Arthritis. The Journal of Rheumatology. 36(6). 1136–1142. 49 indexed citations
19.
He, Jing, Jinxia Zhao, Hui Wang, & Zhanguo Li. (2008). [Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity].. PubMed. 88(9). 625–9. 4 indexed citations
20.
He, Jing, Hui Wang, Jinxia Zhao, & Zhanguo Li. (2008). [Establishment of Sjögren's syndrome models by immunization with alpha-Fodrin: experiment with mice].. PubMed. 88(33). 2360–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026